Weak close for KLCI as Genting sold off

By JOSEPH CHIN

Negative news about Genting's associate TauRX Pharmaceuticals Ltd’s unsuccessful experimental results for its Alzheimer’s drug, LMTX, also weighed on the share price. Also dragging down the market was the slump in crude oil prices.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News
Malaysia's Nov headline inflation at 1.4%, core at 2.2%
Signature Alliance says entering 2026 with positive outlook on RM297.4mil order book
Kelvin Tan Aik Pen returns to Innoprise Plantations as managing director
Bursa Malaysia ends morning session easier
Malaysia's official reserve assets at US$124.12bil as at end-Nov 2025
MSC appoints co-group CEOs
Asian stocks set for strongest annual jump in eight years on AI bets
China's factory activity edges back to growth in December, private PMI shows
Oil slips as Brent heads for longest stretch of annual losses in 2025
Bursa Malaysia poised to wrap 2025 on a multi-year high

Trending in Business

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.